United States ex rel. Dildine v. Pandya

389 F. Supp. 3d 1214
CourtDistrict Court, N.D. Georgia
DecidedJuly 9, 2019
DocketCIVIL ACTION NO. 1:13-CV-03336-LMM
StatusPublished
Cited by7 cases

This text of 389 F. Supp. 3d 1214 (United States ex rel. Dildine v. Pandya) is published on Counsel Stack Legal Research, covering District Court, N.D. Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
United States ex rel. Dildine v. Pandya, 389 F. Supp. 3d 1214 (N.D. Ga. 2019).

Opinion

Leigh Martin May, United States District Judge

This matter is before the Court on Defendants' Motion to Dismiss and to Strike the Intervenor's Complaint [71]. After due consideration, the Court enters the following Order:

I. BACKGROUND

In October 2013, Relator Laura Dildine brought this qui tam action against Dr. Aarti Pandya on behalf of the United States, alleging violations of the federal False Claims Act ("FCA"), 31 U.S.C. § 3729. See Dkt. No. [1]. The United States elected to intervene in June 2018 and filed its Intervenor Complaint ("Complaint") on October 18, 2018. See Dkt. No. [60]. The Government alleges that Defendants knowingly submitted false claims to Medicare and knowingly made or used false records or statements to get false or fraudulent Medicare claims paid by the United States between January 2011 and December 2016 and that such practices resulted in the payment for services that were not medically necessary, never rendered, or not rendered as represented. Id. ¶ 1.

Defendant Dr. Aarti Pandya is an ophthalmologist and the sole owner of the Pandya Practice Group, a private ophthalmology practice in Conyers, Georgia. Id. Relator Laura Dildine formerly worked as the office manager of the Pandya Practice Group from October 2012 to February 2014. Id. ¶ 8. Dr. Pandya has worked at her current ophthalmology practice since completing her residency in 1999, and she became the sole owner of the practice in 2011 when she acquired it from the preceding owner upon his retirement. Id. ¶ 36. The Complaint alleges that upon taking over the practice, "Medicare billings skyrocketed" despite no change in the patient population. Id. ¶¶ 38-39. Specifically, the Complaint references the average number of services billed annually per Medicare beneficiary and claims that the number more than doubled in the first two years of Dr. Pandya's practice ownership. Id. ¶ 40. The Government alleges a search warrant executed in 2014 curtailed the alleged fraudulent Medicare billing practice during that calendar year; however, the heightened Medicare billing resumed the following year in 2015. Id. The Government attributes the increased Medicare billing practice to "multiple schemes, all of which resulted in the submission of false claims ... and, in many cases, placed her patients at risk of serious harm." Id. ¶ 41.

The Complaint divides the alleged false claims into three categories: surgical and laser procedures, diagnostic tests, and office visits. Id. at 14, 32, 61. Each section contains detailed allegations, including specific patient encounters, that highlight the alleged fraudulent practices. Id. at 17, 40, 70.

For example, regarding the surgical and laser procedures, Section One alleges that *1218Dr. Pandya performed cataract surgeries on patients who presented with little or no vision complaints and whose visual acuity would not warrant surgery. Id. ¶ 51. And the Medicare billing data indicates that Dr. Pandya engaged in a practice called "upcoding," in which a provider would bill under a complex surgery procedure code, rather than a routine surgery procedure code, to obtain a higher reimbursement rate. Id. ¶ 72.

Section Two alleges that Dr. Pandya's billing data indicates the use of fraudulent diagnostic practices to increase reimbursement rates. Id. ¶ 110. In 2013, the percentage of Dr. Pandya's Medicare patients diagnosed with a glaucoma-related diagnosis exceeded the national average more than ten times. Id.

Section Three alleges a similar "upcoding" practice for regular office visits-essentially that Dr. Pandya submitted claims with Level 4 and Level 5 procedures codes, codes reserved for more complex office visits, when in fact the visits were non-complex and often limited to five to ten-minute encounters. Id. ¶¶ 177, 194.

Defendants now move to partially dismiss all claims based on cataract procedures and glaucoma tests. See Dkt. No. [71] at 3.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
389 F. Supp. 3d 1214, Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-ex-rel-dildine-v-pandya-gand-2019.